Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma

EGFR-mutant lung adenocarcinomas contain a subpopulation of cells that have undergone epithelial-to-mesenchymal transition and can grow independently of EGFR. To kill these cancer cells, we need a novel therapeutic approach other than EGFR inhibitors. If a molecule is specifically expressed on the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Miki, Hirai, Sachie, Sumi, Toshiyuki, Tanaka, Yusuke, Tada, Makoto, Nishii, Yukari, Hasegawa, Tadashi, Uchida, Hiroaki, Yamada, Gen, Watanabe, Atsushi, Takahashi, Hiroki, Sakuma, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092918/
https://www.ncbi.nlm.nih.gov/pubmed/28433633
http://dx.doi.org/10.1016/j.bbrc.2017.04.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092918/
https://www.ncbi.nlm.nih.gov/pubmed/28433633
http://dx.doi.org/10.1016/j.bbrc.2017.04.102

Ejemplares similares